Emerging Opportunities to Streamline Cancer Drug Development
Participants
Margaret Anderson, MSc
Executive Director
FasterCures
@MargaretAinDC
Roy Baynes, MD, PhD
Senior Vice President and Head
Global Clinical Development
Chief Medical Officer
Merck Research Laboratories
Merck & Co., Inc.
Donald A. Berry, PhD
Professor
Department of Biostatistics
The University of Texas
MD Anderson Cancer Center
Danielle Carnival, PhD
Chief of Staff and Senior Policy Director
White House Cancer Moonshot Task Force
Office of the Vice President
Jason V. Cristofaro, JD, PhD
Intellectual Property Program Manager
Division of Cancer Treatment and Diagnosis
National Cancer Institute
Kathleen A. Denis, PhD
Associate Vice President
The Rockefeller University
Ann M. Geiger, PhD, MPH
Chief
Healthcare Assessment Research Branch
Healthcare Delivery Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
@NCI_AMGeiger
Gary Gilliland, MD, PhD
President and Director
Fred Hutchinson Cancer Research Center
Hill Harper, JD
Member
President’s Cancer Panel
Author, Actor, and
Philanthropist
@hillharper
Clifford A. Hudis, MD, FACP
Chief Executive Officer
American Society of Clinical Oncology
@CliffordHudis
Suleika Jaouad
New York Times Columnist
Young Adult Cancer Advocate
@SuleikaJaouad
Aaron Kesselheim, MD, JD
Associate Professor of Medicine
Harvard Medical School
Director
Program on Regulation, Therapeutics, and Law
Division of Pharmacoepidemiology and Pharmacoeconomics
Brigham and Women's Hospital
@akesselheim
Lisa LaVange, PhD
Director
Office of Biostatistics
Center for Drug Evaluation and Research
U.S. Food and Drug Administration
Lori M. Minasian, MD
Deputy Director
Division of Cancer Prevention
National Cancer Institute
Shelley Fuld Nasso, MPP
Chief Executive Officer
National Coalition for Cancer Survivorship
@sfuldnasso
Richard Pazdur, MD
Acting Director
Oncology Center of Excellence
U.S. Food and Drug Administration
Vinay K. Prasad, MD, MPH
Assistant Professor
Oncology
Oregon Health & Science University
@vinayprasad82
Barbara K. Rimer, DrPH
Chair
President’s Cancer Panel
Dean and Alumni Distinguished Professor
UNC Gillings School of Global Public Health
Mace Rothenberg, MD
Chief Development Officer
Oncology
Pfizer Global Product Development
Pfizer, Inc.
Abby B. Sandler, PhD
Executive Secretary
President's Cancer Panel
Special Assistant to the Director
Rare Tumors Initiative
Center for Cancer Research
National Cancer Institute
George A. Scangos, PhD
Chief Executive Officer
Biogen
Greg Simon, JD
Executive Director
White House Cancer Moonshot Task Force
Office of the Vice President
Philip J. Stella, MD
Medical Director
Oncology Program
St. Joseph Mercy Hospital—Ann Arbor
Owen Witte, MD
Member
President’s Cancer Panel
University Professor
University of California
Director
Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research
University of California, Los Angeles
James Zwiebel, MD
Chief
Investigational Drug Branch
Cancer Therapy Evaluation Program
National Cancer Institute